Updated
MimedxMDXG · Healthcare
$3.31+0.91%
Market cap$483M
IndustryBiotechnology

Mimedx (MDXG) Superinvestor holders

13 of the superinvestors we track hold Mimedx (MDXG) in their latest 13F filings, $54M in total.

Summary

The largest holder is Wilmot Harkey (Nantahala Capital Management), with $18M, 1.1% of the portfolio.

In their latest quarter: 6 added, 7 trimmed.

Who holds it

Each investor's latest 13F filing, largest stake first. What a 13F shows.

InvestorLast changeSharesValue% of portfolioFiled for
Wilmot Harkey
Nantahala Capital Management
Added 4,767,552$18M 1.1%Q2 2026
Cliff Asness
AQR Capital Management
Added 2,467,005$9M 0.0%Q2 2026
Jim Simons
Renaissance Technologies
Trimmed 2,444,230$9M 0.0%Q2 2026
J. Carlo Cannell
Cannell Capital
Added 1,870,436$7M 5.0%Q2 2026
Arrowstreet Capital Added 1,266,571$5M 0.0%Q2 2026
David Shaw
D. E. Shaw & Co.
Added 421,367$2M 0.0%Q2 2026
Two Sigma
Two Sigma Investments
Trimmed 246,625$949,506 0.0%Q2 2026
Paul Marshall
Marshall Wace
Trimmed 204,856$788,695 0.0%Q2 2026
Steve Cohen
Point72 Asset Management
Trimmed 123,557$475,694 0.0%Q2 2026
Paul Tudor Jones
Tudor Investment Corp
Trimmed 53,414$205,644 0.0%Q2 2026
Chuck Royce
Royce Investment Partners
Added 20,072$93,536 0.0%Q3 2026
Alan Howard
Brevan Howard
Trimmed 10,819$41,653 0.0%Q2 2026
Acadian
Acadian Asset Management
Trimmed 5,638$26,000 0.0%Q3 2026

Holders by quarter

QuarterSuperinvestors holding it
Q2 202614
Q1 202617
Q4 202515
Q3 202513
Q2 202510
Q1 202510
Q4 202410
Q3 20249

Questions about Mimedx

Which superinvestors own Mimedx?

13 of the superinvestors we track hold Mimedx (MDXG) in their latest 13F filings, $54M in total. Wilmot Harkey, Cliff Asness, Jim Simons, J. Carlo Cannell, Arrowstreet Capital, David Shaw.

Who is the largest superinvestor holder of MDXG?

The largest holder is Wilmot Harkey (Nantahala Capital Management), with $18M, 1.1% of the portfolio.

From Mimedx's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.

Investingly

Better research starts here.

Every filing, chart and insider trade behind Mimedx and thousands of other companies, in one place. Free to start.